Voglio sapere a riguardo di…

11558

Federal Register / Vol. 86, No. 36 / Thursday, February 25, 2021 / Notices
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia 22152.
In accordance with 21 CFR 1301.33a, this is notice that on July 20, 2020, Chattem Chemicals 3801 Saint Elmo Avenue, Chattanooga, Tennessee 37409, applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:

SUPPLEMENTARY INFORMATION:

Controlled substance
Drug code
Gamma Hydroxybutyric Acid
Marihuana
Tetrahydrocannabinols
4-Methoxyamphetamine
Dihydromorphine
Norlevorphanol
Amphetamine
Methamphetamine
Lisdexamfetamine
Methylphenidate
ANPP 4-Anilino-N-phenethyl-4piperidine.
Phenylacetone
Cocaine
Codeine
Dihydrocodeine
Oxycodone
Hydromorphone
Hydrocodone
Levorphanol
Meperidine
Meperidine intermediateA
Meperidine intermediateB
Meperidine intermediateC
Methadone
Methadone intermediate
Morphine
Oripavine
Thebaine
Opium, powdered
Opium, granulated
Oxymorphone
Noroxymorphone
Racemethorphan
Alfentanil
Remifentanil
Sufentanil
Tapentadol
Fentanyl

Schedule
2010
7360
7370
7411
9145
9634
1100
1105
1205
1724
8333

I
I I
I I
I II
II
II
II
II

8501
9041
9050
9120
9143
9150
9193
9220
9230
9232
9233
9234
9250
9254
9300
9330
9333
9639
9640
9652
9668
9732
9737
9739
9740
9780
9801

II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II

FR Doc. 202103836 Filed 22421; 8:45 am BILLING CODE 441009P

VerDate Sep<11>2014

17:04 Feb 24, 2021

Jkt 253001

Drug Enforcement Administration Docket No. DEA791

Bulk Manufacturer of Controlled Substances Application: S&B Pharma, Inc.
Drug Enforcement Administration, Justice.

AGENCY:
ACTION:

Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 26, 2021. Such persons may also file a written request for a hearing on the application on or before April 26, 2021.

DATES:

Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia 22152.

ADDRESSES:

In accordance with 21 CFR 1301.33a, this is notice that on November 11, 2020, S&B Pharma, Inc., 405 South Motor Avenue, Azusa, California 917023232, applied to be registered as an bulk manufacturer of the following basic classes of controlled substances:

SUPPLEMENTARY INFORMATION:

Gamma Hydroxybutyric Acid
Tetrahydrocannabinols
Amphetamine
Methamphetamine
Lisdexamfetamine
Methylphenidate
Pentobarbital
4-Anilino-N-phenethyl-4-piperidine ANPP.
Tapentadol
Fentanyl

Drug code
Schedule
7360
7370
1100
1105
1205
1724
2270
8333

I
I II
II
II
II
II
II

9780
9801

II
II

The company plans to manufacture the listed controlled substances in bulk for use in product development and for commercial sales to its customers. In reference to drug code 7360 Marihuana and 7370 Tetrahydrocannabinols, the company plans to bulk manufacture both as synthetic substances. No other
Frm 00064

Fmt 4703

DEPARTMENT OF JUSTICE

Docket No. DEA798

Notice of application.

Controlled substance
BILLING CODE 441009P

Drug Enforcement Administration
S&B Pharma, Inc., has applied to be registered as a bulk manufacturer of basic classes of controlled substances. Refer to Supplemental Information listed below for further drug information.

PO 00000

William T. McDermott, Assistant Administrator.
FR Doc. 202103837 Filed 22421; 8:45 am
SUMMARY:

The company plans to manufacturer the listed controlled substances in bulk for distribution and sale to its customers.
In reference to drug code 7360
Marihuana and 7370
Tetrahydrocannabinols, the company plans to bulk manufacture these drugs as a synthetic. No other activities for this drug code are authorized for this registration.
William T. McDermott, Assistant Administrator.

activity for these drug codes is authorized for this registration.

DEPARTMENT OF JUSTICE

Sfmt 4703

Importer of Controlled Substances Application: Myonex Inc Drug Enforcement Administration, Justice.
ACTION: Notice of application.
AGENCY:

Myonex Inc has applied to be registered as an importer of basic classes of controlled substances.
Refer to Supplemental Information listed below for further drug information.

SUMMARY:

Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 29, 2021. Such persons may also file a written request for a hearing on the application on or before March 29, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to: 1 Drug Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and 2 Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34a, this is notice that on January 6, 2021, Myonex Inc, 48 East Main Street, Norristown, Pennsylvania 194014915, applied to be registered as an importer of the following basic classes of controlled substances:
DATES:

Controlled substance Amphetamine
Lisdexamfetamine
Methylphenidate

E:FRFM25FEN1.SGM

25FEN1

Drug code
Schedule
1100
1205
1724

II
II
II